Life Science

Teensy-weensy tweezers

It sometimes taxes my credulity when I hear that measurement and manipulation of individual molecules is possible. At the California-China Connection conference, Leroy Hood talked about chips in development to measure individual molecules in biological studies. I tend to think, “:Aw, c’mon! You’re pullin’ my leg.” But here’s an article about a technique developed at the National Institute of Standards ...

Read More »

California-China connection (1 of 2)

I attended a meeting at UC San Diego last week called the “California-China Connection.” It was organized by the journal Nature and UCSD as a kind of hands-across-the-sea program to bring the heads of Chinese universities with growing biotechnology programs to the US—specifically to fraternize with UCSD faculty—and talk about how each can advance growth in biological science. It makes ...

Read More »

Molecular Medicine: Send in the lawyers (3 of 3)

One of the most interesting aspects of this conference on molecular medicine was a couple of sessions about intellectual property (IP). IP is the mother’s milk of the life science industry. What they have that is really of value is what they know and know how to do. Those intangibles are the gold assets of the industry just as the ...

Read More »

Molecular Medicine: The Molecule Biz (2 of 3)

In the previous installment about the molecular medicine conference, I emphasized that the science of so-called complex, polygenic diseases like cancer is, well, complex. But there are other complications as well in the life science business. Biotechnology and pharmaceuticals are also risky, complicated enterprises from a financial standpoint. In a way it’s kind of a layering of complexities, one atop ...

Read More »